Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Anti-obesity Drugs Market to reach USD 4.25 billion by 2027.

Global Anti-obesity Drugs Market Size study, by Mechanism of Action (Peripherally Acting Drugs, and Centrally Acting Drugs), by Drug Type (Prescription Drugs, and OTC Drugs)and Regional Forecasts 2020-2027

Product Code: HALDAT_45290633
Publish Date: 7-07-2020
Page: 200

Global Anti-obesity Drugs Market is valued approximately USD 1.39 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 15% over the forecast period 2020-2027. Anti-obesity medications help decrease body fat by either decreasing appetite or rising calorie intake. The increases in number of obese patients worldwide are predicted to be exacerbated by the consumption of fast foods coupled with lack of exercise. The intake of unhealthy fast foods, and rising disposable income, fuel consumer demand for anti-obesity therapeutics. Advanced medical research has also contributed significantly to the development of the anti-obesity medicines through drug-producing firms, medical colleges and institutes, and government agencies. For Instance: According to Trust for America’s health, In 2020,The U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country’s obesity crisis. The national adult obesity rate has increased by 26 percent since 2008. However, high costsimpedes the growth of the market over the forecast period of 2020-2027. Also, changing eating habits and rising consumption of fast foods will lead to the adoption & demand for Anti-Obesity Drugs.

The regional analysis of global Anti-obesity Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increase in the obese population and high healthcare spending. Whereas,Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income and rising population would create lucrative growth prospects for the Anti-obesity Drugs market across Asia-Pacific region.

Major market player included in this report are:
Boehringer Ingelheim GmbH
Arena Pharmaceuticals Inc.
Takeda Pharmaceuticals Company Limited
Zydus Cadila
Rhythm Pharmaceuticals
Merck & Co. Inc.
Eisai Co. Ltd.
Novo Nordisk A/S
Orexigen Therapeutics Inc.
GlaxoSmithKline PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Mechanism of Action:
Peripherally Acting Drugs
Centrally Acting Drugs
By Drug Type:
Prescription Drugs
OTC Drugs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Anti-obesity Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Anti-obesity Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Anti-obesity Drugs Market, by Mechanism of action,2018-2027 (USD Billion)
1.2.3. Anti-obesity Drugs Market, by Drug type,2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anti-obesity Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anti-obesity Drugs Market Dynamics
3.1. Anti-obesity Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anti-obesity Drugs MarketIndustry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-obesity Drugs Market, by Mechanism of action
5.1. Market Snapshot
5.2. Global Anti-obesity Drugs Market by Mechanism of action, Performance – Potential Analysis
5.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Mechanism of action2017-2027 (USD Billion)
5.4. Anti-obesity Drugs Market, Sub Segment Analysis
5.4.1. Peripherally Acting Drugs
5.4.2. Centrally Acting Drugs
Chapter 6. Global Anti-obesity Drugs Market, by Drug type
6.1. Market Snapshot
6.2. Global Anti-obesity Drugs Market by Drug type, Performance – Potential Analysis
6.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Drug type2017-2027 (USD Billion)
6.4. Anti-obesity Drugs Market, Sub Segment Analysis
6.4.1. Prescription Drugs
6.4.2. OTC Drugs
Chapter 7. Global Anti-obesity Drugs Market, Regional Analysis
7.1. Anti-obesity Drugs Market, Regional Market Snapshot
7.2. North America Anti-obesity Drugs Market
7.2.1. U.S.Anti-obesity Drugs Market
7.2.1.1. Mechanism of actionbreakdown estimates & forecasts, 2017-2027
7.2.1.2. Drug typebreakdown estimates & forecasts, 2017-2027
7.2.2. CanadaAnti-obesity Drugs Market
7.3. Europe Anti-obesity Drugs Market Snapshot
7.3.1. U.K. Anti-obesity Drugs Market
7.3.2. Germany Anti-obesity Drugs Market
7.3.3. France Anti-obesity Drugs Market
7.3.4. Spain Anti-obesity Drugs Market
7.3.5. Italy Anti-obesity Drugs Market
7.3.6. Rest of EuropeAnti-obesity Drugs Market
7.4. Asia-PacificAnti-obesity Drugs Market Snapshot
7.4.1. China Anti-obesity Drugs Market
7.4.2. India Anti-obesity Drugs Market
7.4.3. JapanAnti-obesity Drugs Market
7.4.4. Australia Anti-obesity Drugs Market
7.4.5. South Korea Anti-obesity Drugs Market
7.4.6. Rest of Asia PacificAnti-obesity Drugs Market
7.5. Latin America Anti-obesity Drugs Market Snapshot
7.5.1. Brazil Anti-obesity Drugs Market
7.5.2. Mexico Anti-obesity Drugs Market
7.6. Rest of The World Anti-obesity Drugs Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim GmbH

8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Arena Pharmaceuticals Inc.
8.2.3. Takeda Pharmaceuticals Company Limited
8.2.4. Zydus Cadila
8.2.5. Rhythm Pharmaceuticals
8.2.6. Merck & Co. Inc.
8.2.7. Eisai Co. Ltd.
8.2.8. Novo Nordisk A/S
8.2.9. Orexigen Therapeutics Inc.
8.2.10. GlaxoSmithKline PLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now